Science News

Nature Medicine, Published online: 11 September 2026; doi:10.1038/s41591-026-04635-9 A 15-year cohort study shows that Alzheimer’s dementia risk is jointly shaped by Alzheimer’s pathology and cognitive resilience, with high resilience linked to lower risk, even under greater pathology. Read More

Science News

Nature Medicine, Published online: 11 September 2026; doi:10.1038/s41591-026-04642-w In the randomized phase 2 ImmunoPRISM trial, patients with high-risk smoldering multiple myeloma (MM) showed higher rates of complete clinical responses in response to treatment with teclistamab compared with lenalidomide–dexamethasone, although longer follow-up is required to determine durable prevention of progression to MM. Read More